Sodium/potassium ratio change was associated with blood pressure change: possibility of population approach for sodium/potassium ratio reduction in health checkup.

Blood pressure Community setting Health checkup site Population approach Urinary Na/K ratio

Journal

Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 07 04 2020
accepted: 15 07 2020
revised: 02 07 2020
pubmed: 18 8 2020
medline: 15 12 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

Recently, the sodium (Na)/potassium (K) ratio was reported to be associated with blood pressure (BP). A Na/K ratio self-monitoring device using spot urine was established recently. Here, we assessed whether the urinary Na/K ratio change measured using the Na/K device was associated with BP change in a health checkup setting. We targeted 12,890 participants who attended the health checkup in Tome City, Miyagi between 2017 and 2018. Tome City introduced urinary Na/K ratio measurements during health checkups since 2017. For each year, we compared the baseline characteristics according to the urinary Na/K ratio and BP level. We assessed the relationship between change in urinary Na/K ratio and BP change using multiple regression analyses adjusted for age, sex, and change in body mass index (BMI) and alcohol intake. The average urinary Na/K ratio was significantly lower in 2018 than in 2017 (5.4 ± 3.0 to 4.9 ± 2.2, P < 0.01). The systolic BP of the participants in 2018 (130.9 ± 17.4 mmHg) was lower than that in 2017 (132.1 ± 17.9 mmHg). Moreover, the change in systolic BP and diastolic BP was positively associated with the change in urinary Na/K ratio. In conclusion, the association of the change in urinary Na/K ratio with hypertension and changes in systolic and diastolic BP can be explained by a change in alcohol intake, BMI, and urinary Na/K ratio. Therefore, measuring the urinary Na/K ratio in community settings is a potential population approach for counteracting hypertension.

Identifiants

pubmed: 32801312
doi: 10.1038/s41440-020-00536-7
pii: 10.1038/s41440-020-00536-7
pmc: PMC7815510
doi:

Substances chimiques

Sodium 9NEZ333N27
Potassium RWP5GA015D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

225-231

Commentaires et corrections

Type : ErratumIn

Références

Tabara Y, Takahashi Y, Kumagai K, Setoh K, Kawaguchi T, Takahashi M, et al. Descriptive epidemiology of spot urine sodium-to-potassium ratio clarified close relationship with blood pressure level: the Nagahama study. J Hypertens. 2015;33:2407–13.
doi: 10.1097/HJH.0000000000000734
Mente A, O’Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371:601–11.
doi: 10.1056/NEJMoa1311989
Jackson SL, Cogswell ME, Zhao L, Terry AL, Wang CY, Wright J, et al. Association between urinary sodium and potassium excretion and blood pressure among adults in the united states: national health and nutrition examination survey, 2014. Circulation. 2018;137:237–46.
doi: 10.1161/CIRCULATIONAHA.117.029193
Higo Y, Nagashima S, Tabara Y, Setoh K, Kawaguchi T, Takahashi Y, et al. Association of the spot urine sodium-to-potassium ratio with blood pressure is independent of urinary Na and K levels: The Nagahama study. Hypertens Res. 2019;42:1624–30.
doi: 10.1038/s41440-019-0276-9
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. J Am Soc Hypertens. 2018;12:579.
doi: 10.1016/j.jash.2018.06.010
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.
doi: 10.1093/eurheartj/ehy339
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.
doi: 10.1038/s41440-019-0284-9
Iwahori T, Miura K, Ueshima H, Tanaka-Mizuno S, Chan Q, Arima H, et al. Urinary sodium-to-potassium ratio and intake of sodium and potassium among men and women from multiethnic general populations: the INTERSALT Study. Hypertens Res. 2019;42:1590–8.
doi: 10.1038/s41440-019-0263-1
Yamashita M, Tabara Y, Higo Y, Setoh K, Kawaguchi T, Takahashi Y, et al. Association between socioeconomic factors and urinary sodium-to-potassium ratio: the Nagahama Study. Hypertens Res. 2018;41:973–80.
doi: 10.1038/s41440-018-0101-x
Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993;20:7–14.
doi: 10.1111/j.1440-1681.1993.tb01496.x
Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16:97–103.
doi: 10.1038/sj.jhh.1001307
Kawano Y, Tsuchihashi T, Matsuura H, Ando K, Fujita T, Ueshima H. Working group for dietary salt reduction of the Japanese Society of Hypertension. Report of the working group for dietary salt reduction of the Japanese Society of Hypertension: (2) Assessment of salt intake in the management of hypertension. Hypertens Res. 2007;30:887–93.
doi: 10.1291/hypres.30.887
Iwahori T, Ueshima H, Ohgami N, Yamashita H, Miyagawa N, Kondo K, et al. Effectiveness of a self-monitoring device for urinary sodium-to-potassium ratio on dietary improvement in freeliving adults: a randomized controlled trial. J Epidemiol. 2018;28:41–7.
doi: 10.2188/jea.JE20160144
Kogure M, Hirata T, Nakaya N, Tsuchiya N, Nakamura T, Narita A, et al. Multiple measurements of the urinary sodium-to-potassium ratio strongly related home hypertension: TMM Cohort Study. Hypertens Res. 2020;43:62–71.
doi: 10.1038/s41440-019-0335-2
Tome City; 2019. https://www.city.tome.miyagi.jp/simin/shisejoho/shinogaiyo/tokejoho/zyuki/zyukizinkousetai.html (in Japanese).
Japan Meteorological Agency; 2019. https://www.data.jma.go.jp/obd/stats/etrn/index.php (in Japanese).
Ministry of Health, Labour and Welfare. National health and Nutrition Survey; 2010. https://www.mhlw.go.jp/bunya/kenkou/eiyou/dl/h22-houkoku-01.pdf (in Japanese).
Pereira TSS, Mill JG, Griep RH, Sichieri R, Molina MDCB. Effect of urinary sodium-to-potassium ratio change on blood pressure in participants of the longitudinal health of adults study—ELSA-Brasil. Medicine. 2019;98:e16278.
doi: 10.1097/MD.0000000000016278
Kieneker LM, Gansevoort RT, Mukamal KJ, de Boer RA, Navis G, Bakker SJ, et al. Urinary potassium excretion and risk of developing hypertension: the prevention of renal and vascular end-stage disease study. Hypertension. 2014;64:769–76.
doi: 10.1161/HYPERTENSIONAHA.114.03750
Mirmiran P, Bahadoran Z, Nazeri P, Azizi F. Dietary sodium to potassium ratio and the incidence of hypertension and cardiovascular disease: a population-based longitudinal study. Clin Exp Hypertens. 2018;40:772–9.
doi: 10.1080/10641963.2018.1431261
Thi Minh Nguyen T, Miura K, Tanaka-Mizuno S, Tanaka T, Nakamura Y, Fujiyoshi A, et al. Association of blood pressure with estimates of 24-h urinary sodium and potassium excretion from repeated single-spot urine samples. Hypertens Res. 2019;42:411–8.
doi: 10.1038/s41440-018-0152-z
Hozawa A, Kuriyama S, Shimazu T, Ohmori-Matsuda K, Tsuji I. Seasonal variation in home blood pressure measurements and relation to outside temperature in Japan. Clin Exp Hypertens. 2011;33:153–8.
doi: 10.3109/10641963.2010.531841
Iwahori T, Ueshima H, Torii S, Saito Y, Kondo K, Tanaka-Mizuno S, et al. Diurnal variation of urinary sodium-to-potassium ratio in free-living Japanese individuals. Hypertens Res. 2017;40:658–64.
doi: 10.1038/hr.2016.187

Auteurs

Mana Kogure (M)

Division of Personalized Prevention and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan. m-kogure@med.tohoku.ac.jp.
Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan. m-kogure@med.tohoku.ac.jp.

Naoki Nakaya (N)

Division of Personalized Prevention and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan.
Department of Health Sciences, Saitama Prefectural University, Koshigaya, Japan.

Takumi Hirata (T)

Division of Personalized Prevention and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan.
Department of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Naho Tsuchiya (N)

Division of Personalized Prevention and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan.

Tomohiro Nakamura (T)

Division of Personalized Prevention and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan.

Akira Narita (A)

Division of Personalized Prevention and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan.

Yoko Suto (Y)

Health Promotion Division, Department of Civic Life Affairs, Tome City, Miyagi, Japan.

Yoko Honma (Y)

Health Promotion Division, Department of Civic Life Affairs, Tome City, Miyagi, Japan.

Hidemi Sasaki (H)

Health Promotion Division, Department of Civic Life Affairs, Tome City, Miyagi, Japan.

Ken Miyagawa (K)

Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan.

Yusuke Ushida (Y)

Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan.

Hiroyuki Ueda (H)

Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan.

Atsushi Hozawa (A)

Division of Personalized Prevention and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Progressive Innovation Research Project (COI Tohoku Site), Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH